Screening. Vulva cancer
The colposcope is not as reliable in ruling out the presence of invasive carcinoma as it is in ruling out cancer of the vagina or cervix. A higher index of suspicion and a large number of biopsies are therefore appropriate in evaluating suspicious vulvar lesions. Canadian viagra without prescription. The difficulty in detecting early invasive cancer of the vulva limits the applicability of laser ablation for management of high-grade or extensive VIN.
The need for radical surgery is based on prognostic factors that are predictive of outcome for invasive carcinoma of the vulva. The detection of nodal metastases during surgical staging is the key finding for determining treatment options. Cialis 20 mg online at cheap pharmacy mall.
The impetus to perform more conservative surgery for invasive cancer has been the realization that radical vulvectomy is associated with severe psychosocial sequelae. When compared with healthy adult women, women who have undergone a vulvectomy report lower levels of sexual arousal and poor body image.
Canadian generic viagra
Screening
No specific screening method is available. The profile of a vulnerable patient should always be considered. The average age at which invasive disease is diagnosed is 65 years. The most frequent symptom is a long history of vulvar itching, and the most common finding is a mass. Less commonly, women present with symptoms such as bleeding, discharge, or even dysuria. On physical examination the lesion is usually raised and appears ulcerated, leukoplakic, or wartlike. Most squamous cell carcinomas are unifocal and occur on the labia majora; however, about 5% are multifocal. Because the etiology of vulvar malignancy remains unknown and no physical features are diagnostic of vulvar carcinoma, it is diagnosed on the basis of biopsy. Most authorities believe that VIN I can be managed expectantly, whereas VIN II-III should be treated.